BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT
The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the H...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RABOISSON PIERRE JEAN-MARIE BERNARD DE KOCK HERMAN AUGUSTINUS VAN DEN EYNDE CHRISTEL FLORENTINA E VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS |
| description | The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2012220520A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2012220520A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2012220520A13</originalsourceid><addsrcrecordid>eNrjZNB28vR3DHP09HF08nFVcPb3dfL0cwzx9PcLVnDzD1LwcA5TCAlydQzxdfUL4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGRkZGBqZGBo6GxsSpAgAIBiXD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT</title><source>esp@cenet</source><creator>RABOISSON PIERRE JEAN-MARIE BERNARD ; DE KOCK HERMAN AUGUSTINUS ; VAN DEN EYNDE CHRISTEL FLORENTINA E ; VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</creator><creatorcontrib>RABOISSON PIERRE JEAN-MARIE BERNARD ; DE KOCK HERMAN AUGUSTINUS ; VAN DEN EYNDE CHRISTEL FLORENTINA E ; VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</creatorcontrib><description>The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120830&DB=EPODOC&CC=US&NR=2012220520A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120830&DB=EPODOC&CC=US&NR=2012220520A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RABOISSON PIERRE JEAN-MARIE BERNARD</creatorcontrib><creatorcontrib>DE KOCK HERMAN AUGUSTINUS</creatorcontrib><creatorcontrib>VAN DEN EYNDE CHRISTEL FLORENTINA E</creatorcontrib><creatorcontrib>VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</creatorcontrib><title>BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT</title><description>The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB28vR3DHP09HF08nFVcPb3dfL0cwzx9PcLVnDzD1LwcA5TCAlydQzxdfUL4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGRkZGBqZGBo6GxsSpAgAIBiXD</recordid><startdate>20120830</startdate><enddate>20120830</enddate><creator>RABOISSON PIERRE JEAN-MARIE BERNARD</creator><creator>DE KOCK HERMAN AUGUSTINUS</creator><creator>VAN DEN EYNDE CHRISTEL FLORENTINA E</creator><creator>VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</creator><scope>EVB</scope></search><sort><creationdate>20120830</creationdate><title>BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT</title><author>RABOISSON PIERRE JEAN-MARIE BERNARD ; DE KOCK HERMAN AUGUSTINUS ; VAN DEN EYNDE CHRISTEL FLORENTINA E ; VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2012220520A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RABOISSON PIERRE JEAN-MARIE BERNARD</creatorcontrib><creatorcontrib>DE KOCK HERMAN AUGUSTINUS</creatorcontrib><creatorcontrib>VAN DEN EYNDE CHRISTEL FLORENTINA E</creatorcontrib><creatorcontrib>VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RABOISSON PIERRE JEAN-MARIE BERNARD</au><au>DE KOCK HERMAN AUGUSTINUS</au><au>VAN DEN EYNDE CHRISTEL FLORENTINA E</au><au>VAN'T KLOOSTER GERBEN ALBERT ELEUTHERIUS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT</title><date>2012-08-30</date><risdate>2012</risdate><abstract>The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2012220520A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A03%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RABOISSON%20PIERRE%20JEAN-MARIE%20BERNARD&rft.date=2012-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2012220520A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |